Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

High-grade cervical disease in adolescents with HIV.

Massad LS, Evans CT, D'Souza G, Darragh T, Minkoff H, Henry D, Goparaju L, Muderspach LI, Watts DH.

J Low Genit Tract Dis. 2008 Jul;12(3):199-203. doi: 10.1097/LGT.0b013e318160b9a5.

2.

Natural history of grade 1 cervical intraepithelial neoplasia in women with human immunodeficiency virus.

Massad LS, Evans CT, Minkoff H, Watts DH, Strickler HD, Darragh T, Levine A, Anastos K, Moxley M, Passaro DJ.

Obstet Gynecol. 2004 Nov;104(5 Pt 1):1077-85.

PMID:
15516404
3.

Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results.

Harris TG, Burk RD, Palefsky JM, Massad LS, Bang JY, Anastos K, Minkoff H, Hall CB, Bacon MC, Levine AM, Watts DH, Silverberg MJ, Xue X, Melnick SL, Strickler HD.

JAMA. 2005 Mar 23;293(12):1471-6.

PMID:
15784870
4.

High-grade squamous intraepithelial lesion in women aged <30 years has a prevalence pattern resembling low-grade squamous intraepithelial lesion.

Vale DB, Westin MC, Zeferino LC.

Cancer Cytopathol. 2013 Oct;121(10):576-81. doi: 10.1002/cncy.21312. Epub 2013 Jun 13.

5.

Risk of cervical precancer and cancer among HIV-infected women with normal cervical cytology and no evidence of oncogenic HPV infection.

Keller MJ, Burk RD, Xie X, Anastos K, Massad LS, Minkoff H, Xue X, D'Souza G, Watts DH, Levine AM, Castle PE, Colie C, Palefsky JM, Strickler HD.

JAMA. 2012 Jul 25;308(4):362-9. doi: 10.1001/jama.2012.5664.

6.

Incidence of cervical precancers among HIV-seropositive women.

Massad LS, Xie X, D'Souza G, Darragh TM, Minkoff H, Wright R, Colie C, Sanchez-Keeland L, Strickler HD.

Am J Obstet Gynecol. 2015 May;212(5):606.e1-8. doi: 10.1016/j.ajog.2014.12.003. Epub 2014 Dec 10.

7.

Cervical dysplasia in adolescents.

Wright JD, Davila RM, Pinto KR, Merritt DF, Gibb RK, Rader JS, Mutch DG, Gao F, Powell MA.

Obstet Gynecol. 2005 Jul;106(1):115-20.

PMID:
15994625
8.

[Cervical intraepithelial neoplasia and genital condylomatosis in HIV-positive patients. Clinical aspects and management].

Penna C, Fallani MG, Zipoli E, Cardelli A, Antonielli C, Marchionni M.

Minerva Ginecol. 1996 Jul-Aug;48(7-8):275-81. Italian.

PMID:
8965999
9.

Prevalence and risk factors for human papillomavirus and cervical intraepithelial neoplasia among HIV-positive women at a tertiary level hospital in India.

Peedicayil A, Thiyagarajan K, Gnanamony M, Pulimood SA, Jeyaseelan V, Kannangai R, Lionel J, Abraham OC, Abraham P.

J Low Genit Tract Dis. 2009 Jul;13(3):159-64. doi: 10.1097/LGT.0b013e31818fb40d.

PMID:
19550213
10.

Effect of human immunodeficiency virus infection on the prevalence and incidence of vaginal intraepithelial neoplasia.

Massad LS, Xie X, Greenblatt RM, Minkoff H, Sanchez-Keeland L, Watts DH, Wright RL, D'Souza G, Merenstein D, Strickler H.

Obstet Gynecol. 2012 Mar;119(3):582-9. doi: 10.1097/AOG.0b013e318244ee3d.

11.

Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. Women's Interagency HIV Study Group.

Massad LS, Riester KA, Anastos KM, Fruchter RG, Palefsky JM, Burk RD, Burns D, Greenblatt RM, Muderspach LI, Miotti P.

J Acquir Immune Defic Syndr. 1999 May 1;21(1):33-41.

PMID:
10235512
12.

Outcome after negative colposcopy among human immunodeficiency virus-infected women with borderline cytologic abnormalities.

Massad LS, Evans CT, Strickler HD, Burk RD, Watts DH, Cashin L, Darragh T, Gange S, Lee YC, Moxley M, Levine A, Passaro DJ.

Obstet Gynecol. 2005 Sep;106(3):525-32.

PMID:
16135582
13.

Incidence of cervical intraepithelial neoplasia in a cohort of HIV-infected women.

Araújo AC, Carvalho NO, Teixeira NC, Souza TT, Murta ED, Faria IM, Corrêa CM, Lima MI, Del Castillo DM, Melo VH.

Int J Gynaecol Obstet. 2012 Jun;117(3):211-6. doi: 10.1016/j.ijgo.2011.12.024. Epub 2012 Mar 22.

PMID:
22445392
14.

Cervical intraepithelial neoplasia and human papillomavirus infection among Senegalese women seropositive for HIV-1 or HIV-2 or seronegative for HIV.

Seck AC, Faye MA, Critchlow CW, Mbaye AD, Kuypers J, Woto-Gaye G, Langley C, De EB, Holmes KK, Kiviat NB.

Int J STD AIDS. 1994 May-Jun;5(3):189-93.

PMID:
8061090
15.
16.

Assessment of risk factors and human papillomavirus (HPV) related pathogenetic mechanisms of CIN in HIV-positive and HIV-negative women. Study design and baseline data of the HPV-PathogenISS study.

Branca M, Costa S, Mariani L, Sesti F, Agarossi A, di Carlo A, Galati M, Benedetto A, Ciotti M, Giorgi C, Criscuolo A, Valieri M, Favalli C, Paba P, Santini D, Piccione E, Alderisio M, De Nuzzo M, di Bonito L, Syrjänen K.

Eur J Gynaecol Oncol. 2004;25(6):689-98.

PMID:
15597844
17.
18.

Bacterial vaginosis as a risk factor for high-grade cervical lesions and cancer in HIV-seropositive women.

Denslow SA, Westreich DJ, Firnhaber C, Michelow P, Williams S, Smith JS.

Int J Gynaecol Obstet. 2011 Sep;114(3):273-7. doi: 10.1016/j.ijgo.2011.03.011. Epub 2011 Jun 16.

PMID:
21683359
19.

Recurrence of high-grade cervical abnormalities following conservative management of cervical intraepithelial neoplasia grade 2.

Wilkinson TM, Sykes PH, Simcock B, Petrich S.

Am J Obstet Gynecol. 2015 Jun;212(6):769.e1-7. doi: 10.1016/j.ajog.2015.01.010. Epub 2015 Jan 9.

PMID:
25582099
20.

Human papillomavirus types among women infected with HIV: a meta-analysis.

Clifford GM, Gonçalves MA, Franceschi S; HPV and HIV Study Group.

AIDS. 2006 Nov 28;20(18):2337-44.

PMID:
17117020

Supplemental Content

Support Center